FLAURA2 shows early EGFR ctDNA clearance is prognostic but does not predict benefit from adding chemotherapy to first-line ...
AstraZeneca today announced the US availability of ZEGFROVY® (sunvozertinib) for the treatment of adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors have ...
Phase 3 trials for three different agents show substantial reductions in kidney function decline and other improvements ...
A central Arkansas father is fighting for his life and hoping a stranger could be the answer to his prayers as he searches ...
While there are many aspects of CKD dietary therapy that are difficult in practice, I believe there are many points to ...
COCOON shows lazertinib lead-in plus simplified prophylaxis reduced grade ≥2 skin toxicity to 18% with SC amivantamab in EGFR ...
Columbia’s Jai Radhakrishnan, MD, MS, explains how FSGS differs by phenotype and why new IgA nephropathy drugs reach so few ...
Your kidneys can quietly lose most of their work before you ever feel anything is wrong, and the signs that do slip through ...
A computational and synthesis study prioritized benzohydrazide compounds 3d and 3f for experimental EGFR testing, while the lack of biological assays means their binding and anticancer activity remain ...
A 19-year single-center study of 516 glioma patients, validated in three public cohorts, shows that high KCNJ11 mRNA ...
Routine lab work helps establish a baseline, monitor metabolic and organ health, catch problems early, and show health factors beyond just the scale. Before prescribing an antiobesity medication, ...
Genmab and Incyte will co-develop a Phase 1/2 trial combining petosemtamab, INCB161734, and chemotherapy for KRAS G12D-mutant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results